Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New tissue-selective androgen receptor agonists developed at Kaken

March 24, 2004

Ezetimibe/simvastatin tablets approved in Mexico

March 23, 2004

Novel NPY antagonists covered by Roche patent

March 23, 2004

Osteoprotegerin impairs fracture healing in rat tibia

March 22, 2004

European orphan drug status for AMT's LPL gene therapy product

March 19, 2004

Merck patent covers new cannabinoid CB1 inhibitors and their use

March 19, 2004

New cannabinoid CB1 antagonists and their use as antiobesity agents

March 19, 2004

SOM-230 reported effective in reducing serum GH levels of acromegalic patients

March 19, 2004

An oral insulin spray enhances the postprandial efficacy of oral hypoglycemic drugs

March 19, 2004

Antisense GHR inhibitor shows promise in animal studies

March 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...